Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain AMS on Instagram
  • World Menopause Day

    World Menopause Day

    Bone Health
    18 October 2021

    Read more

  • AMS Congress

    AMS Congress

    26-28 November 2021
    Adelaide, South Australia

    Read more

  • AMS Webinar

    AMS Webinar

    What’s new - The use of testosterone in women
    Available for viewing now

    Read more

  • Early Menopause and POI

    Early Menopause and POI

    Management resources for women
    and their health professionals

    Read more

  • Health Information

    Health Information

    Find an AMS Doctor, news,
    self-assessment tools and videos

    Read more

  • Health Professionals

    Health Professionals

    Menopause management resources,
    news, position statements

    Read more

  • Menopause management

    Menopause management

    AMS supporting women through
    midlife health and the menopause

    Read more

  • AMS eLearning

    AMS eLearning

    A benefit for AMS Members
    webinars, case studies
    with CPD points

    Read more

  • Menopause Videos

    Menopause Videos

    Explaining issues women
    worry most about

    Read more

AMS Congress

AMS 2021 Congress

Join us in Adelaide from 26-28 Nov for the 24th Annual AMS Congress. Share experiences and knowledge gained as we have all adapted in our approaches to Midlife and Menopause issues across the pandemic. Go to Congress page.

AMS Webinar available to view

AMS Webinar What's new The use of testosterone in women

AMS is pleased to bring you this webinar on the use of testosterone therapy in women. For GPs, endocrinologists, gynaecologists, pharmacists and other healthcare professionals. 
Learn more here.


AMS Members

If your work focuses on menopause and issues related to women's midlife health, become a Member of the AMS. Access information and resources which will inspire and guide improvements for your practice. Members only information.

AMS eLearning

AMS eLearning Website

AMS eLearning is free to register with low cost courses (free for AMS members). Access webinars, case studies, quizzes and other learning that attract 2020-22 CPD points.
Access here.

Health Professionals

Health professionals

Health Professionals includes AMS Congress updates, information sheets, menopause management resources, news, position statements, a selection of studies published, NAMS videos and more... See Health Professionals.

What's New | Features

What's New | Features

View the latest articles available on the AMS website. See What's New here.

View articles, resources, position statement or events of particular interest. See Features here.

Overcoming Barriers to Menopausal Hormone Therapy

Prof Bronwyn Stuckey BA MBBS FRACP

Overcoming Barriers to Menopausal Hormone TherapyTake Home Messages

  • Re-analysis of randomised controlled trials and observational studies suggest that MHT started within ten years of menopause does no cardiovascular harm.
  • A re-analysis of the Nurses’ Health Study showed that no significant increase in breast cancer was identified until after twenty years of oestrogen-only use.
  • Not all MHT preparations have the same risk and side-effect profile; treatment should be individualised to each patient.
  • A recent position statement by the Endocrine Society states that ‘bio-identical’ compounded hormone preparations are untested, unregulated and potentially harmful and should not be prescribed.
  • The menopause consultation should include a full history and physical examination, preventative healthcare and requires time to effectively communicate information.


Today, the life expectancy of the average Australian woman is eighty-seven years. Although this has increased over time with better healthcare, the average age of menopause is fifty-one years and this has not changed. The majority of women will spend over thirty years of their lives in the postmenopausal state. At menopause, most women will experience symptoms ranging from hot flushes, arthralgia, insomnia, cognitive dysfunction, genito-urinary symptoms and reduced libido. Some of these symptoms may or may not resolve with time. Importantly, menopause and the fall in oestrogen leads to bone loss, an unfavourable change in lipids and a rising cardiovascular and stroke risk, which do not resolve with time.

Download to see full mongraph.

pdfOvercoming Barriers to Menopausal Hormone Therapy7.88 MB 


Content updated Febraury 2017



Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgainAMS on Instagram